| Trial Name | SUCCEED |
| Description | Phase III double-blind placebo controlled trial of ridaforolimus for patients responding to chemotherapy for metastatic soft tissue sarcoma |
| Reference | Sponsor: Ariad Pharmaceuticals |
| Status / Sites | CLOSED This study reported at ASCO 2011. |
| UK Chief Investigator Contact | Dr Beatrice Seddon, London |
You are viewing the text version of this site.
To view the full version please install the Adobe Flash Player and ensure your web browser has JavaScript enabled.
Need help? check the requirements page.